Session Track · IDC 2027

Hidradenitis Suppurativa at IDC 2027

Part of the IDC 2027 scientific program · NH Villa Carpegna, Rome, Italy · June 21–23, 2027

About the Hidradenitis Suppurativa Session

Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition characterized by painful, recurrent abscesses and nodules in areas rich in apocrine sweat glands, such as the armpits, groin, and buttocks. The condition typically begins after puberty and can have a significant impact on quality of life due to pain, scarring, and discharge of pus. Diagnosis of HS is based on clinical examination, often requiring a careful assessment of symptoms and physical findings. Treatment options aim to control symptoms, reduce inflammation, and prevent flare-ups. This may include topical or oral antibiotics, corticosteroids, retinoids, or immunosuppressive medications. In severe cases, surgical interventions such as drainage of abscesses, laser therapy, or excision of affected tissue may be necessary. Managing HS often requires a multidisciplinary approach involving dermatologists, surgeons, and other healthcare providers. Lifestyle modifications, such as weight loss and smoking cessation, may also help improve symptoms. Additionally, support groups and counseling can be beneficial for individuals coping with the emotional and psychological impact of HS. While HS can be challenging to treat, ongoing research is providing insights into the underlying mechanisms of the disease and leading to the development of new therapeutic approaches. Early diagnosis and intervention are essential for minimizing complications and improving outcomes for individuals living with HS.

Featured Speakers — Hidradenitis Suppurativa 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Hidradenitis Suppurativa Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IDC 2027

Why Attend the Hidradenitis Suppurativa Conference 2027

Present Your Research

Oral and poster slots for original Hidradenitis Suppurativa work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Hidradenitis Suppurativa research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same program, same certificate.

Join IDC 2027 for the Hidradenitis Suppurativa track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Hidradenitis Suppurativa Conference 2027 — FAQs

What is the Hidradenitis Suppurativa track at IDC 2027?

The Hidradenitis Suppurativa track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Hidradenitis Suppurativa. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Hidradenitis Suppurativa sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Hidradenitis Suppurativa are all welcome — whether presenting or attending.

Can I present my research in the Hidradenitis Suppurativa track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Hidradenitis Suppurativa sessions?

Yes. IDC 2027 is a hybrid conference — attend the Hidradenitis Suppurativa track in person in Rome or join live online, with on-demand access afterward.

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.